ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: type 1 diabetes

Data Collection Drives Evaluation of Psoriasis Treatments

Michele B. Kaufman, PharmD, BCGP  |  June 10, 2015

For six years, the Psoriasis Longitudinal Assessment and Registry (PSOLAR) has collected data to assess the infection risk for drugs treating systemic psoriasis.

Filed under:Biologics/DMARDsDrug Updates Tagged with:adverse drug reactionBiologicsPsoriasisPsoriasis Longitudinal Assessment and Registry

FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors

Michele B. Kaufman, PharmD, BCGP  |  May 20, 2015

Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders

Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate

Gretchen Henkel  |  March 1, 2015

Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:ArthritisdebateglucocorticoidHenkelrheumatologistSteroidtherapy

Giant Cell Arteritis Challenging to Diagnose, Manage

Sebastian Unizony, MD, and John H. Stone, MD, MPH  |  March 1, 2015

Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

Filed under:ConditionsResearch RheumVasculitis Tagged with:DiagnosisGiant Cell ArteritisResearchrheumatologyTreatmentVasculitis

The Rheumatologist as Detective

Charles Radis, DO  |  February 1, 2015

A case of difficult-to-diagnose Whipple’s disease

Filed under:Conditions Tagged with:rheumatologist

Apolipoprotein E Polymorphism Associated with Hyperuricemia in Chinese Population

Lara C. Pullen, PhD  |  December 12, 2014

Researchers find link between hyperuricemia and higher serum uric acid levels in patients with APOE ε2ε3 genotype and APOE-ε2 allele

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:GouthyperuricemiaResearchrheumatologyUric acid

Sugary Soft Drinks Can Raise Risk of Rheumatoid Arthritis

Richard Quinn  |  November 21, 2014

Study finds consuming one or more sugar-sweetened sodas daily can increase women’s chance of developing seropositive RA by more than 60%

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Rheumatoid arthritisrisk

Google Glass Has Potential for Rheumatology, Orthopedic Surgery

Karandeep Singh, MD, Gunnar O. Klein, MD, PhD, & Johan von Heideken, MD, PhD  |  November 2, 2014

Wearable smart-glass device could enable untethered access to electronic health records, be conduit for clinical decision making

Filed under:AppsEMRsTechnology Tagged with:electronic health recordorthopedicrheumatologistsurgeryTechnology

Gout, Glucose Metabolism and Obesity: A Case Review

Lindsey A. MacFarlane, MD, Daniel H. Solomon, MD, MPH, and Seoyoung C. Kim, MD, ScD, MSCE  |  November 2, 2014

New research explores association between hyperurecimia and gout with metabolic derangement

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:GoutKimmetabolismResearchrheumatologistrheumatology

Patients with Rheumatoid Arthritis Should Exercise More, Sit Less

Lynne Feehan, PhD, PT, and Marie Westby, PhD, PT  |  November 1, 2014

Physical activity can improve mobility, strength and bone health, reduce fall risk for patients with RA

Filed under:ConditionsPatient PerspectivePractice SupportQuality Assurance/ImprovementRheumatoid Arthritis Tagged with:Exercisepatient carephysical activityRheumatoid arthritisrheumatologists

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences